Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis

BACKGROUND: Verification of cerebrospinal fluid (CSF) biomarkers for multiple sclerosis and other neurological diseases is a major challenge due to a large number of candidates, limited sample material availability, disease and biological heterogeneity, and the lack of standardized assays. Furthermo...

Descripción completa

Detalles Bibliográficos
Autores principales: Guldbrandsen, Astrid, Lereim, Ragnhild Reehorst, Jacobsen, Mari, Garberg, Hilde, Kroksveen, Ann Cathrine, Barsnes, Harald, Berven, Frode S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499868/
https://www.ncbi.nlm.nih.gov/pubmed/32963504
http://dx.doi.org/10.1186/s12014-020-09296-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499868/
https://www.ncbi.nlm.nih.gov/pubmed/32963504
http://dx.doi.org/10.1186/s12014-020-09296-5

Ejemplares similares